The biocorona: a challenge for the biomedical application of nanoparticles

Abstract Formation of the biocorona on the surface of nanoparticles is a significant obstacle for the development of safe and effective nanotechnologies, especially for nanoparticles with biomedical applications. Following introduction into a biological environment, nanoparticles are rapidly coated with biomolecules resulting in formation of the nanoparticle-biocorona. The addition of these biomolecules alters the nanoparticle’s physicochemical characteristics, functionality, biodistribution, and toxicity. To synthesize effective nanotherapeutics and to more fully understand possible toxicity following human exposures, it is necessary to elucidate these interactions between the nanoparticle and the biological media resulting in biocorona formation. A thorough understanding of the mechanisms by which the addition of the biocorona governs nanoparticle-cell interactions is also required. Through elucidating the formation and the biological impact of the biocorona, the field of nanotechnology can reach its full potential. This understanding of the biocorona will ultimately allow for more effective laboratory screening of nanoparticles and enhanced biomedical applications. The importance of the nanoparticle-biocorona has been appreciated for a decade; however, there remain numerous future directions for research which are necessary for study. This perspectives article will summarize the unique challenges presented by the nanoparticle-biocorona and avenues of future needed investigation.

[1]  K. Landfester,et al.  Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition. , 2015, Nanoscale.

[2]  Krishnendu Roy,et al.  Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition. , 2013, Therapeutic delivery.

[3]  Effects of surface functional groups on the formation of nanoparticle-protein corona. , 2012, Applied physics letters.

[4]  A. Rao,et al.  Influence of carbon nanomaterial defects on the formation of protein corona. , 2015, RSC advances.

[5]  A. Neves,et al.  Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E , 2016, Journal of Nanobiotechnology.

[6]  Morteza Mahmoudi,et al.  Biological Identity of Nanoparticles In Vivo: Clinical Implications of the Protein Corona. , 2017, Trends in biotechnology.

[7]  Christoffer Åberg,et al.  Mapping protein binding sites on the biomolecular corona of nanoparticles. , 2015, Nature nanotechnology.

[8]  W. Bai,et al.  Implications of scavenger receptors in the safe development of nanotherapeutics. , 2015, Receptors & clinical investigation.

[9]  Giulio Caracciolo,et al.  Effect of polyethyleneglycol (PEG) chain length on the bio-nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells. , 2014, Nanoscale.

[10]  A. Allen,et al.  Dissolution, agglomerate morphology, and stability limits of protein-coated silver nanoparticles. , 2014, Langmuir : the ACS journal of surfaces and colloids.

[11]  Achyut J. Raghavendra,et al.  From the Cover: Disease-Induced Disparities in Formation of the Nanoparticle-Biocorona and the Toxicological Consequences. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  Andrew Emili,et al.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.

[13]  Ramakrishna Podila,et al.  Formation of a protein corona on silver nanoparticles mediates cellular toxicity via scavenger receptors. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  R. Podila,et al.  A hyperspectral and toxicological analysis of protein corona impact on silver nanoparticle properties, intracellular modifications, and macrophage activation , 2015, International journal of nanomedicine.

[15]  Paolo Bergese,et al.  Surfactant titration of nanoparticle-protein corona. , 2014, Analytical chemistry.

[16]  Jim E Riviere,et al.  A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles. , 2016, Nanomedicine.

[17]  Andrzej S Pitek,et al.  Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials. , 2015, Nanoscale.

[18]  Yoram Cohen,et al.  Evaluation of Toxicity Ranking for Metal Oxide Nanoparticles via an in Vitro Dosimetry Model. , 2015, ACS nano.

[19]  Bengt-Harald Jonsson,et al.  Protein adsorption onto silica nanoparticles: conformational changes depend on the particles' curvature and the protein stability. , 2004, Langmuir : the ACS journal of surfaces and colloids.

[20]  A. Salvati,et al.  Balancing the effect of corona on therapeutic efficacy and macrophage uptake of lipid nanocapsules. , 2015, Biomaterials.

[21]  C. Scoglio,et al.  Predicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modeling. , 2015, Nanomedicine.

[22]  Hari Sowrirajan,et al.  Impact of Silver and Iron Nanoparticle Exposure on Cholesterol Uptake by Macrophages , 2017, Journal of nanomaterials.

[23]  Warren C. W. Chan,et al.  Polyethylene glycol backfilling mitigates the negative impact of the protein corona on nanoparticle cell targeting. , 2014, Angewandte Chemie.

[24]  Sara Linse,et al.  Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.

[25]  Marco P Monopoli,et al.  Biomolecular coronas provide the biological identity of nanosized materials. , 2012, Nature nanotechnology.

[26]  K. Dawson,et al.  Magnetic nanoparticles to recover cellular organelles and study the time resolved nanoparticle-cell interactome throughout uptake. , 2014, Small.

[27]  Joel G Pounds,et al.  ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies , 2010, Particle and Fibre Toxicology.

[28]  K. Fent,et al.  Silver nanoparticles induce endoplasmatic reticulum stress response in zebrafish. , 2013, Toxicology and applied pharmacology.

[29]  A. Neves,et al.  Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E , 2015, Nanotechnology.

[30]  Abhinav Kumar,et al.  Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[31]  Warren C. W. Chan,et al.  Understanding and Controlling the Interaction of Nanomaterials with Proteins in a Physiological Environment , 2012 .

[32]  Marilena Hadjidemetriou,et al.  In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles. , 2015, ACS nano.

[33]  J. Kreuter Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB) , 2013, Journal of microencapsulation.

[34]  Jin Won Hyun,et al.  Endoplasmic reticulum stress signaling is involved in silver nanoparticles-induced apoptosis. , 2012, The international journal of biochemistry & cell biology.

[35]  Jelena Srebric,et al.  Advanced computational modeling for in vitro nanomaterial dosimetry , 2015, Particle and Fibre Toxicology.

[36]  Frank A. Witzmann,et al.  Silver Nanoparticle Protein Corona Composition in Cell Culture Media , 2013, PloS one.

[37]  Andrzej S Pitek,et al.  Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. , 2012, ACS nano.

[38]  Jiwen Zheng,et al.  Silver Nanoparticle-Induced Autophagic-Lysosomal Disruption and NLRP3-Inflammasome Activation in HepG2 Cells Is Size-Dependent. , 2016, Toxicological sciences : an official journal of the Society of Toxicology.

[39]  S. Homer-Vanniasinkam,et al.  Scavenger Receptor Structure and Function in Health and Disease , 2015, Cells.

[40]  Iseult Lynch,et al.  Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Aristidis Tsatsakis,et al.  Protein bio-corona: critical issue in immune nanotoxicology , 2016, Archives of Toxicology.

[42]  Kenneth A Dawson,et al.  Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. , 2013, Journal of the American Chemical Society.

[43]  Iseult Lynch,et al.  Formation and characterization of the nanoparticle-protein corona. , 2013, Methods in molecular biology.

[44]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[45]  Fengjuan Wang,et al.  The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[46]  Jim E Riviere,et al.  Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? , 2013, Toxicology letters.

[47]  Joel M. Cohen,et al.  A critical review of in vitro dosimetry for engineered nanomaterials. , 2015, Nanomedicine.

[48]  C. Payne,et al.  Impact of Serum Proteins on MRI Contrast Agents: Cellular Binding and T2 relaxation. , 2014, RSC advances.

[49]  Murali M. Yallapu,et al.  Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. , 2015, Biomaterials.

[50]  Stefan Tenzer,et al.  Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. , 2011, ACS nano.

[51]  Diego Stéfani T. Martinez,et al.  Silver nanoparticle protein corona and toxicity: a mini-review , 2015, Journal of Nanobiotechnology.

[52]  Philip M. Kelly,et al.  Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. , 2013, Nature nanotechnology.

[53]  Ran Chen,et al.  Comparison of nanotube-protein corona composition in cell culture media. , 2013, Small.

[54]  Sung Tae Kim,et al.  Regulation of Macrophage Recognition through the Interplay of Nanoparticle Surface Functionality and Protein Corona. , 2016, ACS nano.

[55]  M. Engelhard,et al.  Comparison of 20 nm silver nanoparticles synthesized with and without a gold core: Structure, dissolution in cell culture media, and biological impact on macrophages. , 2015, Biointerphases.